Standard chemotherapy does not work as a standard instrument for all cancer patients. A targeted therapy for a few does not offer a solution either. In order to truly personalise the cancer therapy, it is necessary to have a powerful global marker – one that is able to answer the question as to which cancer therapy works for one patient and which does not. A marker of this kind requires an absolutely precise marker test. The good news is: MARK53 represents both.